ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

KLAS Reports Significant Time Saved with Surescripts Medication Prior Authorization Innovations, Leveraging Clinical Intelligence, Collaboration

Surescripts®, the nation's leading health information network, shares the promising results of a new technology that enabled greater workflow efficiency and faster approvals for prior authorizations for prescription medications, featured in a new KLAS K2 Collaborative Case Study, Leveraging Innovative Technology to Streamline Medication Prior Authorizations.

The KLAS case study highlights key outcomes of a Surescripts-led collaboration with three organizations, including Cleveland Clinic, another healthcare system, and a pharmacy benefit manager. Together, they conducted an innovative demonstration that leveraged clinical intelligence to advance electronic prior authorizations for prescription medications, supporting greater workflow efficiency while maintaining essential clinical integrity.

Key outcomes from the KLAS case study include:

  • Reduction in approval time, leading to faster prescription access for patients: The healthcare organizations reported that with the previous, manual process, prior authorizations for GLP-1 medications took 15.0–20.0 minutes; with the automation, that time has dropped to an average of 0.5–3.0 minutes.

  • Increase in automated approvals: 62% of approvals for in-scope medications (of which there are now over 20) are now automated, leading to 25% of applicable prior authorization requests being automatically approved.

  • Improvement in provider experience: For in-scope medications, there has been an 88% reduction in appeals and a 68% reduction in denials caused by a lack of information.

  • Decrease in physician abandonment rate: The percentage of requests for which physicians receive a question set for additional information but never complete it (i.e., the physician abandonment rate) has dropped from 31% to 25%.

  • Improved efficiency: The automation has improved provider efficiency with administrative processes, giving providers more time to focus on patient care. It has also saved substantial FTE time, which can be repurposed to other tasks.

Obtaining prior authorization for prescription medications can be a necessary step for patients to leverage their health plan benefits for the treatments they need. However, the process often requires overburdened providers to complete multiple manual, time-consuming steps to track down clinical information, including sending faxes and making phone calls. A recent survey showed clinicians who prescribe, including 65% of physicians, physician assistants and nurse practitioners, as well as 57% of pharmacists, indicate that reducing administrative tasks would have the greatest positive impact on patient care and health.

“We know that there is a heavy administrative burden for clinicians, pharmacies, and benefit plans related to medication-related prior authorizations,” said Tara Dragert, Chief Product Officer for Surescripts. “Reducing the time spent sending faxes and making phone calls means clinicians can spend more time caring for patients, which is critical to how we are helping healthcare heal itself.”

According to the KLAS case study, Surescripts technology provided “automation [that] has reduced approval times, denial rates, and physician abandonment rates, resulting in quicker access for patients to needed medication.”

“This project demonstrated the power of tackling shared challenges with innovative technology and cross-industry collaboration. And when trusted intelligence on benefits and authorizations is leveraged at the right time, patients get high-quality, affordable care sooner, creating a better experience that supports better outcomes,” added Dragert. “We thank the Surescripts Network Alliance® members who participated and look forward to continuing to expand our impact and improving patient care together.”

Background:

An American Medical Association survey indicates that 78% of physicians said the prior authorization process sometimes causes their patients to abandon treatment, 94% said it delays necessary care, and 79% said it can lead patients to pay for medications out of pocket. Physicians and their staff also reported spending an average of 12 hours a week completing prior authorizations and said that phone was the most commonly used method. Virtually all (95%) said that the process increases physician burnout.

A majority of pharmacists and prescribers described following up on prior authorizations as “very frustrating” in a 2021 Surescripts survey. and a quarter of pharmacists still used fax to process them.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.